Impact of the daily use of an emollient+ on corticosteroid consumption in children and adults with atopic dermatitis

H. Zelenkova, A.-L. Demessant, S. Samir, D. Kerob

 

INTRODUCTION

Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by eczema and itching. AD starts in early childhood in more than 85% of patients but can persist or sometimes start in adulthood. Educational programs and daily emollients/emollients+ are the basis of AD treatment to restore skin barrier and prevent flares, while topical corticosteroids (TCS) are used to manage AD flares. An Emollient+ with active ingredients including Shea Butter, Niacinamide, Thermal Spring Water (TSW), APF (a biomass of Vitreoscilla Filiformis grown in TSW) and Microresyl has been developed to restore physical and microbial skin barrier, preventing the excessive proliferation of Staphylococcus aureus. This study was designed to evaluate the cortico-sparing effect of the Emollient+ compared to usual emollients.